Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biocryst Pharma Inc
(NQ:
BCRX
)
5.630
+0.310 (+5.83%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biocryst Pharma Inc
< Previous
1
2
3
4
5
6
Next >
10 Health Care Stocks Whale Activity In Today's Session
April 11, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Oppenheimer Maintains Outperform Rating for BioCryst Pharmaceuticals, Lowers Price Target To $16
April 11, 2022
Oppenheimer has decided to maintain its Outperform rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) and lower its price target from $20.00 to $16.00. Shares of BioCryst Pharmaceuticals are trading down...
Via
Benzinga
Why BioCryst Pharmaceuticals Stock Is Falling
April 11, 2022
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) shares are trading lower Monday morning after BofA Securities downgraded the stock and Oppenheimer lowered its price target.
Via
Benzinga
Mid-Afternoon Market Update: Nasdaq Falls 150 Points; Crude Oil Rises 2%
April 08, 2022
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping more than 100 points on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
April 08, 2022
Gainers Phio Pharma (NASDAQ:PHIO) shares increased by 46.7% to $1.33 during Friday's regular session. As of 13:31 EST, Phio Pharma's stock is trading at a volume...
Via
Benzinga
Read Here Why Did BioCryst Stopped Enrollment In BCX9930 Studies In Rare Blood Disorder
April 08, 2022
Via
Benzinga
Can Recent Catalysts Breakout BioCryst To New Highs?
February 09, 2022
In today’s volatile markets, finding a biotech stock that isn’t purely speculative can be challenging, and yet BCRX may have what it takes.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For April 11, 2022
April 11, 2022
Upgrades
Via
Benzinga
28 Stocks Moving In Friday's Mid-Day Session
April 08, 2022
Gainers Lyra Therapeutics, Inc. (NASDAQ: LYRA) shares climbed 33.3% to $5.78 as the company reported a private placement for gross proceeds of $110.5 million. TSR, Inc. (NASDAQ...
Via
Benzinga
BioCryst Is On Fire: What Do Options Traders Expect Next?
January 12, 2022
Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) sur...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
April 08, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Mid-Day Market Update: Dow Jumps Over 200 Points; Sunshine Biopharma Shares Slide
April 08, 2022
U.S. stocks traded mixed midway through trading, with the Dow Jones surging more than 200 points on Friday.
Via
Benzinga
Mid-Morning Market Update: Markets Edge Lower; US Wholesale Inventories Rise 2.5% In February
April 08, 2022
U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping 100 points on Friday.
Via
Benzinga
Why BioCryst Pharmaceuticals Stock Is Plunging Today
April 08, 2022
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) shares are trading significantly lower Friday after the company paused enrollment in clinical trials with BCX9930 while it ...
Via
Benzinga
Biocryst Pharmaceuticals Stock Shows Rising Price Performance With Jump To 92 RS Rating
March 23, 2022
Biotech Biocryst Pharmaceuticals stock had its Relative Strength (RS) Rating upgraded from 88 to 92 Wednesday.
Via
Investor's Business Daily
BioCryst Continues To Develop A Strong Pipeline
March 15, 2022
Investing in biotech stocks often comes with huge risks and rewards, as a company is dependent on its pipeline and royalty payments.
Via
Talk Markets
BioCryst's Orladeyo Shows Long Term Benefit With Sustained Reductions in Attack Rates
February 24, 2022
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) announced new long-term efficacy and safety data from the APeX-2 trial evaluating Orladeyo (berotralstat) for the...
Via
Benzinga
Recap: BioCryst Pharmaceuticals Q4 Earnings
February 23, 2022
BioCryst Pharmaceuticals (NASDAQ:BCRX) reported its Q4 earnings results on Wednesday, February 23, 2022 at 07:00 AM. Here's what investors need to know about the...
Via
Benzinga
BioCryst Hit 15-Year Highs But What's In Store Tomorrow For Earnings?
February 22, 2022
By StoryTrading BioCryst’s (NASDAQ: BCRX) stock price hit 15-year highs since our article was published on Benzinga earlier this month, but with the oral prophylactic...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
February 18, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Is BioCryst (BCRX) Ready to Breakout to New Highs on Recent Catalysts?
February 09, 2022
By Ben Rabizadeh – Fundamentals well positioned with $1B peak sales forecast for Orladeyo and $300M influx of cash from royalty deals – Potential catalysts: update on Orladeyo sales with Q4 results on...
Via
Benzinga
If You Invested $1000 In This Stock 10 Years Ago, Here's How Much You Would Have Today
January 12, 2022
BioCryst Pharmaceuticals (NASDAQ:BCRX) has outperformed the market over the past 10 years by 5.6% on an annualized basis. Buying $1,000 In BCRX: 10 years ago, an investor could...
Via
Benzinga
60 Biggest Movers From Yesterday
January 11, 2022
Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares surged 57.1% to close at $5.39 on Monday. Zynga Inc. (NASDAQ: ZNGA) rose 40.7% to settle at $8.44 after the company...
Via
Benzinga
Biotech Bloodbath Continues Despite Gene-Editing Deals For Pfizer, Bayer
January 10, 2022
Pfizer and Bayer inked deals with several companies in gene-editing.
Via
Investor's Business Daily
45 Stocks Moving In Monday's Mid-Day Session
January 10, 2022
Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares climbed 71.5% to $5.88. Zynga Inc. (NASDAQ: ZNGA) gained 45.7% to $8.74 after the company announced it will be acquired...
Via
Benzinga
3 Stocks Insiders Are Buying
November 26, 2021
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, t...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021
December 10, 2021
Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE:
Via
Benzinga
BioCryst Shares Gain As Royalty Pharma Buys Additional Interests In BCX9930, Orladeyo
November 22, 2021
Royalty Pharma plc (NASDAQ: RPRX) and OMERS Capital Markets have announced transactions worth $350 million in new funding in BioCryst Pharmaceuticals...
Via
Benzinga
7 Top Growth Stocks to Buy as We Step Into November
November 12, 2021
Here are seven top growth stocks investors may want to consider when looking at options in this hyper-growth market right now.
Via
InvestorPlace
86 Biggest Movers From Yesterday
November 04, 2021
Gainers FAT Brands Inc. (NASDAQ: FATBB) shares gained 99.2% to settle at $15.44. FAT Brands recently announced plans to acquire Fazoli’s Restaurant Chain for $130 million....
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.